BeStock  
Stocks › Biotechnology › GYRE

Gyre Therapeutics GYRE

US equityMarket cap rank #3650Biotechnology
$4.76 +$0.75 (+18.70%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $4.76 0.00%
Open$4.56
Prev close$4.01
Day range$4.08 – $4.79
Volume359.7K
Market cap$504.72M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts2
Average target$19.00+299.2% vs. price
  • Buy 100%
Low $18.00Now $4.76Avg $19.00High $20.00

Recent rating changes

The last 19 actions on file set price targets from $16.00 to $20.00, averaging $18.63.

DateFirmRatingTarget
5 Oct 2026 H.C. Wainwright BUY $18.00
10 Aug 2026 Noble Financial BUY $20.00
7 Aug 2026 H.C. Wainwright BUY $18.00
8 May 2026 Noble Financial BUY $20.00
7 May 2026 H.C. Wainwright BUY $18.00
17 Mar 2026 H.C. Wainwright BUY $18.00
13 Mar 2026 Noble Financial BUY $20.00
12 Mar 2026 H.C. Wainwright BUY $18.00
3 Mar 2026 Noble Financial BUY $20.00
2 Mar 2026 H.C. Wainwright BUY $18.00
6 Jan 2026 Noble Financial BUY $20.00
6 Jan 2026 H.C. Wainwright BUY $18.00
10 Nov 2025 Noble Financial BUY $20.00
10 Nov 2025 H.C. Wainwright BUY $18.00
7 Nov 2025 H.C. Wainwright BUY $18.00
3 Nov 2025 Noble Financial BUY $20.00
29 Oct 2025 H.C. Wainwright BUY $18.00
15 Oct 2025 H.C. Wainwright BUY $18.00
10 Oct 2025 Jefferies BUY $16.00

Discussion

No comments yet — be the first to weigh in on GYRE.

Sign in to join the discussion.

Scroll to Top